Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?

Slides:



Advertisements
Similar presentations
Setting Goals of Care. SSC 2012 Guidelines Setting Goals of Care We recommend that goals of care and prognosis be discussed with patients and families.
Advertisements

Multimodal Management of Opioid-Induced Constipation
Applying the New Multiple Sclerosis Guidelines to Clinical Practice
Acute Hypertension Management Optimizing Door-to-Needle Time in Ischemic Stroke.
Making the Case for Metabolic Surgery in Patients With Obesity and T2DM.
Making Decisions With Your Osteoarthritis Patients
Starting Strong: Initial Evaluation of the Patient With HCV
Optimizing Therapy for Osteoarthritis
A Paradigm Shift in PAH.
Preventing SCD With a WCD: Reviewing the Results of the VEST Trial
Introduction/Background
Introducing JAK Inhibitors in Rheumatoid Arthritis
UNDERSTANDING RISK STRATIFICATION IN PAH:
Current Controversies in Multiple Sclerosis Management
Modern Strategies for Basal Insulin Use in T2D
Patient Case Discussions in T2D: What Intensification Plan Is Best?
Managing Comorbidities in Patients With Rheumatoid Arthritis
Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.
Getting the Best out of Guidelines in the Rapidly Changing Landscape of RA Treatment.
Optimal Use of New Fentanyl Formulations for BTCP in Asia
Clinical Considerations in Evidence-based Management of GIST
Minding the Gap Rheumatoid Arthritis Advances From London 2016
Anticoagulation Therapy in Patients Post-TAVR
Counseling Patients About Germline BRCA Mutations
PAH in Adults CHEST Guideline and Expert Panel Report: Grading of Evidence
Precision Management of RA and Comorbidities
Clinical Updates in RA: New Developments and Insights From Washington
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
Are We Closer to Personalized Medicine in MS?
Applying Real-World Evidence in Atrial Fibrillation Into Clinical Care:
Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.
Case Collection in RA: Highlights of an Interactive Workshop
Is RA Treatment Addressing the Real Needs of Patients?
Program Goals. Treatment-Naive Patients With PAH What Do We Know and What Choices Do We Have?
Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.
Avoiding Opioid Overuse: Guideline-Based Management of Osteoarthritis
VTE in Cancer.
OTC NSAID Use in Patients With OA and CV Disease
Examining the Latest Evidence in PAH
Debating the Issues in Rheumatoid Arthritis with the Experts: Early Treatment and Targets.
Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis.
Treating to Target in MS
Overcoming Clinical Inertia
Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
Advances in Rheumatoid Arthritis Management
What's New in Therapeutic Options for Moderate to Severe RA?
The Road to Quality Improvement in HER2-Positive Breast Cancer
Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.
PAH-Related Morbidity as a Predictor of Mortality
Viewpoints of Practicing Rheumatologists: Case Discussions in RA
Diabetes Pandemic. The Economics of Managing Patients With Diabetes and Coronary Artery Disease: A Payer Perspective.
Updates on the Prevention and Management of CINV
Maximizing Organ Protection in Patients With CKD and Comorbidities on RAAS Therapy.
Perspective on the Multidisciplinary Management of PAH
Clinical Challenges and Updates in Managing Seizure Clusters
Assessing the Burden of Hyperkalemia
Disease Burden of VTE Phases of VTE Treatment.
Selecting Treatment Approaches in Hemophilia
Optimal Treatment of PAH
Assessing the Burden of Hyperkalemia
Clinical Considerations in Evidence-based Management of GIST
Championing Evidence-Based Care in Patients With Acute Low Back Pain
Optimizing Treatment of Refractory Gout
Uptitration of Medications in HF: Start Low but Aim High and Stay High
Clinical response in patients with early and established RA at month 24. *p
Risk Stratification of Patients With Type 2 Diabetes: An Interpretation of the Latest Treatment Guidelines.
Disease Activity Cutoffs for ACR-Recommended RA Disease Activity Measure
Meet the JAKs.
Treating Pulmonary Embolism Today
Presentation transcript:

Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?

Program Goals

Rationale for Evidence-Based Clinical Practice Recommendations

Evidence-Based Medicine for Optimal Guideline Development

GRADE Method Defining Recommendations

2015 ACR RA Guidelines What Is Covered

Initiating Treatment for Early and Established RA

2015 ACR RA Guidelines

Recommendations for High-Risk Patients

Recommendations for High-Risk Patients (cont)

Recommendations for High-Risk Patients (cont)

Recommendations for High-Risk Patients (cont)

2015 ACR RA Guidelines Possible Controversies

2015 ACR RA Guidelines Summary

2015 ACR RA Guidelines Looking Ahead

Abbreviations